- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04078373
Urinary Disorders in Subacute Patients After Stroke (UIMK)
December 5, 2024 updated by: University Rehabilitation Institute, Republic of Slovenia
Assessment and Treatment of Urinary Disorders in Patients in the Subacute Phase After Stroke
This observational study will address urinary disorders in subacute stroke patients.
Patients without and with urinary disorders will be compared, and treatment outcome will be assessed among the latter.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
This prospective observational study will include 100 patients after first ischaemic or hemorrhagic stroke directly transferred from an acute hospital to our Institute for inpatient rehabilitation.
Within admission assessment, patients will be classified according to stroke type, stroke localisation and time since stroke.
Comorbidities will be recorded and associated neurological deficits will be assessed.
Post mictional residue will be determined in all patients one day after admission.
The patients with urinary disorders will be treated according to the published official protocol, either using the immediate urination approach or the bladder diary approach.
Continence will be regularly assessed by the nursing staff.
Urination-disorder-related complications (pressure ulcers, falls and urinary infections), drug therapy and the use of continence aids will also be followed.
Study Type
Observational
Enrollment (Estimated)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Helena Burger, MD, PhD
- Phone Number: +386 1 4758440
- Email: helena.burger@ir-rs.si
Study Contact Backup
- Name: Nataša Bizovičar, MD, PhD
- Phone Number: +386 1 4758361
- Email: natasa.bizovicar@ir-rs.si
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- University Rehabilitation Institute, Republic of Slovenia
-
Contact:
- Helena Burger, MD, PhD
- Phone Number: +386 1 4758440
- Email: helena.burger@ir-rs.si
-
Contact:
- Nataša Bizovičar, MD, PhD
- Phone Number: +386 1 4758351
- Email: natasa.bizovicar@ir-rs.si
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Subacute patients after ischaemic or hemorrhagic stroke directly transferred from an acute hospital to complex inpatient rehabilitation
Description
Inclusion Criteria:
- subacute patients after ischaemic or hemorrhagic stroke;
- direct transfer from acute hospital to complex inpatient rehabilitation at our Institute.
Exclusion Criteria:
- incontinence before stroke;
- previous brain injury or other brain disease;
- previous bladder or prostate surgery;
- inability to ambulate before stroke;
- terminal disease with expected survival less than three months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Without urinary disorders
Subacute stroke patients without urinary disorders
|
|
|
With urinary disorders
Subacute stroke patients with urinary disorders
|
Patients with decreased cognitive ability will be taught to immediately go to the toilet upon feeling the urge to urinate and to be independent in urinating.
Patients with normal cognitive abilities will be instructed to go to the toilet every 2-3 hours regardless of the urge to urinate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Degree of urinary continence
Time Frame: Through study completion, for an average of 6 weeks
|
Urinary continence will be assessed daily by the nursing staff as either complete, partial or incontinence
|
Through study completion, for an average of 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of urinary-disorders-related complications
Time Frame: Through study completion, for an average of 6 weeks
|
Pressure ulcers, falls and urinary infections caused by urinary disorders will be recorded
|
Through study completion, for an average of 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nataša Bizovičar, MD, PhD, University Rehabilitation Institute, Republic of Slovenia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
August 29, 2019
First Submitted That Met QC Criteria
August 31, 2019
First Posted (Actual)
September 6, 2019
Study Record Updates
Last Update Posted (Actual)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 5, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Ischemic Stroke
- Hemorrhagic Stroke
- Stroke
- Urinary Incontinence
Other Study ID Numbers
- URIS201901
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
-
Duke UniversitySociety of Urodynamics and Female Pelvic Medicine & Urogenital ReconstructionTerminatedUrinary Urge IncontinenceUnited States
-
University Hospital, GhentRecruitingIncontinence, Urge | Incontinence Stress | Incontinence, Daytime Urinary | Incontinence, Nighttime UrinaryBelgium
Clinical Trials on Immediate urination
-
Ankara City Hospital BilkentCompletedUrologic Diseases | Benign Prostatic Hyperplasia | Urinary Obstruction | Urinary Tract Disease | Micturition DisorderTurkey
-
Assaf-Harofeh Medical CenterUnknown
-
Cairo UniversityCompleted
-
Holland Bloorview Kids Rehabilitation HospitalActive, not recruitingCerebral Palsy | Chronic PainCanada
-
St. Louis UniversityAmerican Academy of PediatricsWithdrawnMeconium Aspiration Syndrome
-
University of MichiganUniversity of Miami; Beth Israel Deaconess Medical Center; University of Alabama... and other collaboratorsRecruiting
-
Federal University of Rio Grande do SulRecruiting
-
University Hospital, ToulouseRecruitingAllergy and ImmunologyFrance
-
Menoufia UniversityRecruiting
-
Cairo UniversityCompletedImmediate Implant With Bone GraftEgypt